A combination therapeutic implant consisting of metal-based nanomedicine reinforced with patient derived blood clotting components reduces localised tumour recurrence post-surgery. The technology can be used to fabricate a therapeutic kit that can generate this autologous hybrid implant by using simple equipment such as handheld homogenizer and a centrifuge which might be beneficial …
Read More »